rhinitis%20-%20nonallergic
RHINITIS - NONALLERGIC
Nonallergic rhinitis is the inflammation of the nasal lining membranes without any immunoglobulin E mediation, as documented by allergen skin testing.
Major signs and symptoms include nasal itching, watery rhinorrhea, nasal obstruction/congestion, sneezing and postnasal drainage.
Symptoms can reverse spontaneously with or without treatment.

Principles of Therapy

  • If possible, treatment should be aimed at the underlying causative physiology of nonallergic rhinitis
  • No single medication or individual medication class can treat the entire spectrum of symptoms
  • Treatment response may be less satisfactory than in allergic rhinitis

Pharmacotherapy

Anticholinergics (Nasal)
  • Block the muscarinic receptors of the seromucinous glands
  • Ideal for patients who present only w/ rhinorrhea
  • Have no activity against sneezing, itching or nasal congestion
Antihistamines (Nasal)
  • H1-receptor antagonists reduce nasal itching, sneezing & rhinorrhea, but are less effective for nasal obstruction
  • May have limited benefit in nonallergic rhinitis unless symptoms result from histamine release
  • Oral antihistamines may be used as adjunctive therapy in some patients; topical antihistamines have shown better efficacy for non-allergic rhinitis
Corticosteroids (Nasal)
  • Reduce airway hyperresponsiveness, amount & activity of inflammatory mediators, & allow relaxation of smooth muscle
  • Decrease sneezing, pruritus, rhinorrhea & nasal obstruction
  • Recommended as 1st-line treatment for symptoms of nonallergic rhinitis
  • Onset of action is relatively slow (6-12 hours), w/ maximum efficacy developing after 2-3 weeks
  • Better response is achieved w/ continuous use rather than w/ as-required use
  • Patient should be maintained on the lowest dose which achieves symptom control
  • Aqueous preparations are preferred because they are less irritating to the nasal mucosa
  • Intranasal corticosteroids w/ low bioavailability is suggested since it has been shown to have no effect on growth
Decongestants
  • Provoke vasoconstriction by acting on adrenergic receptors, thus relieving swelling of the nasal mucosa
Nasal Decongestants
  • Very effective in relieving nasal obstruction
  • Because of the risk of rebound vasodilation (rhinitis medicamentosa) & atrophic rhinitis w/ prolonged use, their use should be limited to <10 days
Oral Decongestants
  • Have weaker effect on nasal obstruction than topical preparations, but do not cause rebound vasodilatation
  • May be given to patients w/ nasal congestion unresponsive to intranasal corticosteroids, Azelastine, or a combination of both

Non-Pharmacological Therapy

Nasal Saline Irrigation
  • Nasal lavage or saline spray is useful for postnasal drainage symptoms
  • Cleanses nasal mucosa when used before intranasal corticosteroids or Azelastine
Other Investigational Agents
  • Some studies show benefit of Capsaicin, Ribomunyl & Silver nitrate for rhinitis symptoms
    • Capsaicin & Silver nitrate may be used for vasomotor rhinitis & Ribomunyl for infectious rhinitis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, Yesterday
Treatment with oral thrombopoietin receptor agonist eltrombopag leads to similar platelet counts in patients with chronic immune thrombocytopaenia (cITP) and persistent (per)ITP, according to the results of phase III (EXTEND) and IV studies presented at the 23rd Congress of the European Hematology Association (EHA 2018) held in Stockholm, Sweden.
Pearl Toh, 4 days ago
Lonely people were twice as likely to die from any cause than people who did not feel lonely, according to a study based on a national survey presented at the recent EuroHeartCare 2018 in Dublin, Ireland. Also, loneliness is associated with poorer patient-reported outcomes in terms of mental and physical health in patients with heart disease.
15 Jun 2018
Higher activity of plasma xanthine oxidase appears to be linked to insulin resistance and liver dysfunction among type 2 diabetes mellitus (T2DM) patients with metabolic syndrome (MetS), according to a recent Japan study.
Jairia Dela Cruz, Yesterday
A treatment regimen combining daratumumab plus bortezomib, melphalan and prednisone markedly extends progression-free survival in patients with multiple myeloma, inducing deep responses and demonstrating acceptable tolerability regardless of baseline renal function, according to the results of the phase III ALCYONE study.